Condition
Liver Disease (Alcoholic or Not)
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07570901CompletedPrimary
Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients
NCT07250919Completed
Donor and Recipient Mismatch in Liver Transplantation
NCT07206875Not Yet Recruiting
Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders
NCT02650115CompletedPrimary
Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples (MICRONACH)
Showing all 4 trials